VolitionRx Limited Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
VolitionRx Limited (VNRX) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $10.69 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-08-13
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $10.69K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $21.55K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $21.43K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $5.20K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $10.69K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $21.55K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $21.43K 10-K · filed 2026-03-31 |
| 2025-09-30 | $5.20K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $10.24K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $15.56K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $20.75K 10-K · filed 2025-03-31 |
| 2023-09-30 | $19.63K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $43.05K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $63.49K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |